Proteomic signatures predictive of left ventricular reverse remodelling upon restored aortic or mitral valve functio

Not Applicable

• Conditions: I34; I35; Nonrheumatic mitral valve disorders; Nonrheumatic aortic valve disorders

• Registration Number: DRKS00018986
• Lead Sponsor: niversitaets-Herzzentrum Freiburg/Bad Krozingen Abteilung für Herz- und Gefässchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients with the diagnosis of: mitral or aortic regurgitation, benign cardiac tumors, tricuspid valve regurgitation, isolated ascendig aneurysm without concomittant aortic regurgitation

Exclusion Criteria

Isolated coronary artery disease requireing surgical revascularisation
missing consent to take part in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Biochemical and echocardiographic markers in relation to cardiac function after surgical corrective therapy in patients with aortic or mitral regurgitation.

Secondary Outcome Measures

Name	Time	Method
no secondary endpoints defined